(Q45607250)

14 December 2017

Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial (English)

1 reference

14 December 2017

Sanju Yadav

1

1 reference

14 December 2017

Sheetal Agarwal

2

1 reference

14 December 2017

Arti Maria

3

1 reference

14 December 2017

Ajay Dudeja

4

1 reference

14 December 2017

N K Dubey

5

1 reference

14 December 2017

Puneet Anand

6

1 reference

14 December 2017

Dinesh Kumar Yadav

7

1 reference

14 December 2017

17 January 2014

1 reference

14 December 2017

1 reference

14 December 2017

35

1 reference

14 December 2017

5

1 reference

14 December 2017

824-830

1 reference

https://scigraph.springernature.com/pub.10.1007/s00246-014-0861-2

14 December 2017

0 references

cites work

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Patent ductus arteriosus: evidence for and against treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Pharmacokinetics of oral ibuprofen in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Treatment of patent ductus arteriosus with ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-014-0861-2

Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies

21 January 2018

1 reference

12 December 2020

A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.

1 reference

12 December 2020

Ibuprofen treatment of patent ductus arteriosus

1 reference

12 December 2020

Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial

1 reference

12 December 2020

Pharmacological closure of the patent ductus arteriosus.

1 reference

12 December 2020

Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.

1 reference

12 December 2020

Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study

1 reference

12 December 2020

Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.

1 reference

12 December 2020

Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants.

1 reference

12 December 2020

Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility.

1 reference

12 December 2020

Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis

1 reference

12 December 2020

10.1007/S00246-014-0861-2

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference